REFERENCES
- Ladis V, Chouliaras G, Berdousi H, Longitudinal study of survival and causes of death in patients with thalassemia major in Greece. Ann N Y Acad Sci. 2005; 1054:445–450.
- Borgna-Pignatti C, Cappellini MD, Survival and complications in thalassemia. Ann N Y Acad Sci. 2005; 1054:40–47.
- Cherchi GB, Pacifico L, Cossellu S, De Stephano P, Prospective study of Yersinia enterocolitica infection in thalassemic patients. Pediatr Infect Dis J. 1995; 14(7):579–584.
- Adamkiewicz TV, Berkovitch M, Krishnan C, Infection due to Yersinia enterocolitica in a series of patients with β-thalassemia: incidence and predisposing factors. Clin Infect Dis. 1998; 27(6):1362–1366.
- Kwong L, Low LCK, Lau YL. Yersinia enterocolitica infection in thalassemia major. HK J Pediatr. 1992; 9(1):88–91.
- Chung BH, Ha SY, Chan GC, Klebsiella infection in patients with thalassemia. Clin Infect Dis. 2003; 36(5):575–579.
- Wang SC, Lin KH, Chern JP, Severe bacterial infection in transfusion-dependent patients with thalassemia major. Clin Infect Dis. 2003; 37(7):984–988.
- Wanachiwanawin W. Infections in E-β thalassemia. J Pediatr Hematol Oncol. 2000; 22(6):581–587.
- Byers BR, Massad G, Barghouthi S, Arceneaux JE. Iron acquisition and virulence in the motile aeromonads: siderophore-dependent and -independent systems. Experientia. 1991; 47(5):416–418.
- Miles AA, Khimji PL. Enterobacterial chelators of iron: their occurrence, detection, and relation to pathogenicity. J Med Microbiol. 1975; 8(4):477–490.
- Robins-Browne RM, Prpic JK. Effects of iron and desferrioxamine on infections with Yersinia enterocolitica. Infect Immun. 1985; 47(3):774–779.
- Schubert S, Autenrieth IB. Conjugation of hydroxyethyl starch to desferrioxamine (DFO) modulates the dual role of DFO in Yersinia enterocolitica infection. Clin Diagn Lab Immunol. 2000; 7(3):457–462.
- Autenrieth IB, Bohn E, Ewald JH, Heesemann J. Deferoxamine B but not deferoxamine G1 inhibits cytokine production in murine bone marrow macrophages. J Infect Dis. 1995; 172(2):490–496.
- Lesic B, Foulon J, Carniel E. Comparison of the effects of deferiprone versus deferoxamine on growth and virulence of Yersinia enterocolitica. Antimicrob Agents Chemother. 2002; 46(6):1741–1745.
- Hershko C, Link G, Konijn AM, Cabantchik ZI. Objectives and mechanism of iron chelation therapy. Ann N Y Acad Sci. 2005; 1054:124–135.
- Yu WL, Ko WC, Cheng KC, Lee CC, Comparison of prevalence of virulence factors for Klebsiella pneumoniae liver abscesses between isolates with capsular K1/K2 and non-K1/K2 serotypes. Diagn Microbiol Infect Dis. 2008; 62(1):1–6.
- Lawlor MS, O'Connor C, Miller VL. Yersiniabactin is a virulence factor for Klebsiella pneumoniae during pulmonary infection. Infect Immun. 2007; 75(3):1463–1472.
- Stintzi A, Barnes C, Xu J, Raymond KN. Microbial iron transport via a siderophore shuttle: a membrane ion transport paradigm. Proc Natl Acad Sci U S A. 2000; 97(20):10691–10696.